|
Curcumin Clinical Trials
3 actively recruiting trials across 1 location
Also known as: Bio-Curcumin(BCM-95CG), CurQfen, Curcumagalactomannoside (CGM), Tumeric, biocurcumax (BCM-95)
Pipeline
Phase 3: 2
Top Sponsors
- yair lotan1
- University of Texas Southwestern Medical Center1
- Addis Ababa University1
Indications
- Cancer3
- Prostate Cancer2
- Cervical Cancer1
Dallas, Texas2 trials
Adjuvant Curcumin to Assess Recurrence Free Survival in Patients Who Have Had a Radical Prostatectomy
UT Southwestern Medical Center
Phase 3
Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance
UT Southwestern Medical Center
Phase 3
Other1 trial
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.